Correlation Between Regeneron Pharmaceuticals and Ardelyx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Ardelyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Ardelyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Ardelyx, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Ardelyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Ardelyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Ardelyx.

Diversification Opportunities for Regeneron Pharmaceuticals and Ardelyx

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Regeneron and Ardelyx is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Ardelyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ardelyx and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Ardelyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ardelyx has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Ardelyx go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Ardelyx

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Ardelyx. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 2.83 times less risky than Ardelyx. The stock trades about -0.4 of its potential returns per unit of risk. The Ardelyx is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  601.00  in Ardelyx on August 30, 2024 and sell it today you would lose (32.00) from holding Ardelyx or give up 5.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Regeneron Pharmaceuticals  vs.  Ardelyx

 Performance 
       Timeline  
Regeneron Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Ardelyx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ardelyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Ardelyx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Regeneron Pharmaceuticals and Ardelyx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regeneron Pharmaceuticals and Ardelyx

The main advantage of trading using opposite Regeneron Pharmaceuticals and Ardelyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Ardelyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ardelyx will offset losses from the drop in Ardelyx's long position.
The idea behind Regeneron Pharmaceuticals and Ardelyx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio